CONRAY

This brand name is authorized in Canada, United States, South Africa

Active ingredients

The drug CONRAY contains one active pharmaceutical ingredient (API):

1 Iotalamic acid UNII XUW72GOP7W - IOTHALAMATE MEGLUMINE

Iotalamic acid is intended for use as a diagnostic radiopaque medium. It is used in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography. Read about Iotalamic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CONRAY Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08AA04	Iotalamic acid	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media
Discover more medicines within V08AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00131237
Country: US	FDA, National Drug Code	Identifier(s): 0019-0953, 0019-3183
Country: ZA	Health Products Regulatory Authority	Identifier(s): D/28/212